Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Chronic polyradiculoneuritis and its frontiers].

J M Vallat1, F Tabaraud, L Magy

  • 1Service de Neurologie, CHU de Limoges.

Revue Neurologique
|April 15, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

New double homozygous GDAP1 variations associated with polyneuropathy and prominent inflammatory features in unrelated individuals from Indian Ocean islands.

Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology·2025
Same author

Transthyretin amyloid polyneuropathy in France: A cross-sectional study with 413 patients and real-world tafamidis meglumine use (2009-2019).

Revue neurologique·2024
Same author

Transient hemi-parkinsonism due to deep brain venous edema induced by severe intracranial hypotension, a case report.

Revue neurologique·2023
Same author

Current clinical management of CIDP with immunoglobulins in France: An expert opinion.

Revue neurologique·2023
Same author

French recommendations for the management of adult & pediatric chronic inflammatory demyelinating polyradiculoneuropathy (CIDP).

Revue neurologique·2022
Same author

[Muscular weakness and weight loss in à 44 year-old man].

La Revue de medecine interne·2021
Same journal

Macrophage inclusions in patients undergoing antisense oligonucleotide therapy for ALS or SMA: A retrospective and transversal study.

Revue neurologique·2026
Same journal

Geographic disparities in MRI features of ischemic stroke and small vessel disease: A comparative study between French Guiana and mainland France. Findings from the BECATOUR multicenter registry.

Revue neurologique·2026
Same journal

Continuous subcutaneous perfusion of apomorphine in Parkinson's disease: Towards monotherapy?

Revue neurologique·2026
Same journal

Neuro-Whipple presenting as autoimmune encephalitis.

Revue neurologique·2026
Same journal

Multimodal assessment of minimally conscious state and cognitive motor dissociation in neurocritical care: A critical review.

Revue neurologique·2026
Same journal

Development of a new episodic memory assessment tool (NEM): Preliminary data and clinical perspectives.

Revue neurologique·2026
See all related articles

Chronic Inflammatory Demyelinating Polyradiculoneuropathies (CIDP) are likely underestimated. This review covers updated diagnostic criteria and recognizes axonal involvement, aiding in identifying treatable dysimmune neuropathies.

Area of Science:

  • Neurology
  • Immunology
  • Peripheral Nervous System Disorders

Context:

  • Chronic Inflammatory Demyelinating Polyradiculoneuropathies (CIDP) incidence is challenging to ascertain and likely underdiagnosed.
  • Recent years have seen evolving understanding and diagnostic approaches to CIDP and related neuropathies.
  • Traditional diagnostic criteria, like those from the 1991 American Academy of Neurology, face scrutiny for sensitivity.

Purpose:

  • To review recent advancements concerning the scope and diagnosis of CIDP.
  • To discuss updated electrophysiological diagnostic criteria for CIDP.
  • To highlight various forms of chronic dysimmune demyelinating neuropathies and their diagnostic challenges.

Summary:

  • Explores the underestimation of CIDP incidence and prevalence.

Related Experiment Videos

  • Examines evolving diagnostic criteria, particularly electrophysiological measures, addressing limitations of older standards.
  • Differentiates CIDP from related conditions like Lewis and Sumner syndrome and multifocal inflammatory demyelinating neuropathy.
  • Emphasizes the frequent, and sometimes predominant, axonal involvement in CIDP, which can mislead diagnosis towards primary axonal neuropathy.

    • Impact:

    • Improved recognition of chronic dysimmune neuropathies, including CIDP.
    • Facilitates earlier and more accurate diagnosis of these conditions.
    • Supports the effective use of immunosuppressive therapies for recognized chronic dysimmune neuropathies.